COVID-19 infection after oocyte retrieval did not have detrimental effects on embryo implantation for frozen embryo transfer.

Publisher: Wiley-Liss Country of Publication: United States NLM ID: 7705876 Publication Model: Print Cited Medium: Internet ISSN: 1096-9071 (Electronic) Linking ISSN: 01466615 NLM ISO Abbreviation: J Med Virol Subsets: MEDLINE

Publication: New York Ny : Wiley-Liss
Original Publication: New York, Liss.

Abortion, Spontaneous*/epidemiology ; Abortion, Spontaneous*/etiology ; COVID-19* ; Infertility, Female*/therapy; Female ; Pregnancy ; Humans ; Oocyte Retrieval ; Retrospective Studies ; Embryo Implantation ; Embryo Transfer

Patients preparing for their renewal fertility treatments with embryos frozen before coronavirus disease 2019 (COVID-19) infection do not need to be concerned about the potential impact of COVID-19 infection on oocyte quality and embryonic development. However, many women are still hesitant to undergo frozen embryo transfer (FET) due to fear of the detrimental effect of COVID-19 infection on endometrial receptivity and embryo implantation. The objective was to explore whether COVID-19 infection after oocyte retrieval is related to an increased risk of adverse pregnancy outcomes in a cohort of Chinese women undergoing FET. A retrospective cohort study was conducted among 300 infertile women undergoing FET with embryos frozen before COVID-19 infection. Women were categorized into noninfection, infection before FET, or infection after FET groups. Multivariable logistic regression was performed to assess the association of COVID-19 infection with clinical pregnancy outcomes, including biochemical pregnancy, clinical pregnancy, and early miscarriage. The implantation rates for patients in the group with infection before FET (29.14%) and the group with infection after FET (30.38%) were not significantly lower than those in the noninfection group (31.03%). The rate of biochemical pregnancy (54.55% vs. 52.27%, p = 0.750; 43.14% vs. 52.27%, p = 0.209) was not significantly different among the three groups. Although the clinical pregnancy rate showed a declining trend from 45.45% in the noninfection group to 38.27% in the group with infection after FET, this result was not statistically significant. The early miscarriage rate was similar in the group with infection before FET and the group with infection after FET compared with that in the noninfection group (3.64% vs. 5.68%, p = 0.496; 6.86% vs. 5.68%, p = 0.739). After adjusting for potential confounders, the biochemical pregnancy rate, clinical pregnancy rate, and early miscarriage rate were not significantly different for patients with infection before or after FET compared with patients without infection. This research indicated that COVID-19 infection after oocyte retrieval with embryos frozen before infection did not cause any detrimental effect on endometrial receptivity for embryo implantation.
(© 2023 Wiley Periodicals LLC.)

Zhu N, Zhang D, Wang W, et al. A novel coronavirus from patients with pneumonia in China, 2019. N Engl J Med. 2020;382:727-733.
Tangcharoensathien V, Bassett MT, Meng Q, Mills A. Are overwhelmed health systems an inevitable consequence of covid-19? Experiences from China, Thailand, and New York State. BMJ. 2021;372:n83.
World Health Organization. WHO coronavirus (COVID-19) dashboard. Accessed April 10, 2023. https://covid19.who.int/.
Roberts CM, Levi M, McKee M, Schilling R, Lim WS, Grocott MPW. COVID-19: a complex multisystem disorder. Br J Anaesth. 2020;125:238-242.
Batiha O, Al-Deeb T, Al-zoubi E, Alsharu E. Impact of COVID-19 and other viruses on reproductive health. Andrologia. 2020;52:e13791.
Kumari N, Kumari N, Mishra S. Potential impact of COVID-19 on female reproductive health. JBRA Assist Reprod. 2023;27:92-96.
Chi J, Gong W, Gao Q. Clinical characteristics and outcomes of pregnant women with COVID-19 and the risk of vertical transmission: a systematic review. Arch Gynecol Obstet. 2021;303:337-345.
Chandi A, Jain N. State of assisted reproduction technology in the coronavirus disease 2019 era and consequences on human reproductive system. Biol Reprod. 2021;105:808-821.
Henarejos-Castillo I, Devesa-Peiro A, de Miguel-Gomez L, et al. Predicted COVID-19 molecular effects on endometrium reveal key dysregulated genes and functions. Mol Hum Reprod. 2022;28:gaac035.
Weinerman R. COVID-19 and the endometrium: inflammation as understanding. Fertil Steril. 2022;118:1170-1171.
De miguel-Gómez L, Romeu M, Castells-Ballester J, et al. Undetectable viral RNA from SARS-CoV-2 in endometrial biopsies from women with COVID-19: a preliminary study. Am J Obstet Gynecol. 2022;226:434-437.
Jackson CB, Farzan M, Chen B, Choe H. Mechanisms of SARS-CoV-2 entry into cells. Nat Rev Mol Cell Biol. 2022;23:3-20.
Henarejos-Castillo I, Sebastian-Leon P, Devesa-Peiro A, Pellicer A, Diaz-Gimeno P. SARS-CoV-2 infection risk assessment in the endometrium: viral infection-related gene expression across the menstrual cycle. Fertil Steril. 2020;114:223-232.
Li J, Yin M, Wang B, et al. The effect of storage time after vitrification on pregnancy and neonatal outcomes among 24 698 patients following the first embryo transfer cycles. Hum Reprod. 2020;35:1675-1684.
Du T, Chen H, Fu R, et al. Comparison of ectopic pregnancy risk among transfers of embryos vitrified on day 3, day 5, and day 6. Fertil Steril. 2017;108:108-116.e1.
Wedner-Ross S, Schippert C, Von versen-Höynck F. The impact of the COVID-19 pandemic on women seeking fertility treatment: the patient's perspective. Arch Gynecol Obstet. 2022;305:1615-1624.
Orvieto R, Segev-Zahav A, Aizer A. Does COVID-19 infection influence patients’ performance during IVF-ET cycle?: an observational study. Gynecol Endocrinol. 2021;37:895-897.
Youngster M, Avraham S, Yaakov O, et al. IVF under COVID-19: treatment outcomes of fresh ART cycles. Hum Reprod. 2022;37:947-953.
Wang M, Yang Q, Ren X, et al. Investigating the impact of asymptomatic or mild SARS-CoV-2 infection on female fertility and in vitro fertilization outcomes: a retrospective cohort study. EClinicalMedicine. 2021;38:101013.
Morris RS. SARS-CoV-2 spike protein seropositivity from vaccination or infection does not cause sterility. F&S Rep. 2021;2:253-255.
Aizer A, Noach-Hirsh M, Dratviman-Storobinsky O, et al. The effect of coronavirus disease 2019 immunity on frozen-thawed embryo transfer cycles outcome. Fertil Steril. 2022;117:974-979.
Youngster M, Avraham S, Yaakov O, et al. The impact of past COVID-19 infection on pregnancy rates in frozen embryo transfer cycles. J Assist Reprod Genet. 2022;39:1565-1570.
Vilella F, Wang W, Moreno I, Roson B, Quake SR, Simon C. Single-cell RNA sequencing of SARS-CoV-2 cell entry factors in the preconceptional human endometrium. Hum Reprod. 2021;36:2709-2719.

Keywords: COVID-19 infection; SARS-CoV-2; embryo implantation; in vitro fertilization; pregnancy outcomes

Date Created: 20230824 Date Completed: 20230825 Latest Revision: 20230907

20240829

10.1002/jmv.29054

37615372